PHS-001 📄 Overview A SaMD platform integrating longitudinal patient data (EHR, genomics, lifestyle, sensor data) with advanced AI to predict individual health risks for chronic conditions and acute events (e.g., cardiovascular events, diabetes progression) before symptom onset, enabling personalized preventative interventions and early clinical pathway initiation. Key technologies: 👤 Target users: 👍 Benefits Significant reduction in chronic disease incidence • Earlier diagnosis and intervention • Reduced healthcare costs through prevention • Improved patient outcomes and QALYs • Personalized preventative health plans Use bullets or new lines. 👎 Challenges Data interoperability and standardization across diverse sources • Clinical validation in diverse real-world populations • Ensuring algorithmic fairness and mitigating bias • Physician adoption and trust in AI-driven insights • Data privacy and security at scale 📋 Regulatory & Validation Likely Class II SaMD due to diagnostic/predictive function • Requires rigorous clinical evidence for safety and efficacy claims • FDA/MDCG guidance on AI/ML-based SaMD for algorithm transparency and 'locked' vs. 'adaptive' models • Strong cybersecurity measures given sensitive data handling